insights_auto
Why is ALC up 3,09%?
Dive Deeperchevron_right
ALC:NYSE
Alcon AG
73,66 US$
arrow_upward
+3,09%(+2,21) 1D
2 ნოე, 14:40:28 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
72,06 US$
High
74,19 US$
Low
72,03 US$
Mkt. cap
30,22 მლრდ.
Avg. vol.
1,65 მლნ.
Volume
1,10 მლნ.
52-wk high
87,64 US$
52-wk low
61,84 US$
Beta
0,88
Shares outstanding
483,40 მლნ.
No. of employees
25 ათ.
Open
72,06 US$
High
74,19 US$
Low
72,03 US$
Mkt. cap
30,22 მლრდ.
Avg. vol.
1,65 მლნ.
Volume
1,10 მლნ.
52-wk high
87,64 US$
52-wk low
61,84 US$
Beta
0,88
Shares outstanding
483,40 მლნ.
No. of employees
25 ათ.
News stories
From web sources and news partners
Investing.com
·
7 საათის წინ
Needham reiterates Alcon stock rating on Neurotech acquisition
Yahoo! Finance Canada
·
2 დღის წინ
Alcon Inc. (ALC) Seasonal Returns Chart - Yahoo Finance
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEOდავიდ ჯეი ენდიკოტ
Employees25 ათ.
Founded1945
Headquartersჟენევა, ჟენევის კანტონი, შვეიცარია
SectorMedical device
Websitealcon.com